TherapeuticsMD Inc (TXMD) Actualités

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported...

Form AW - Amendment Withdrawal Request

Form 10-Q - Quarterly report [Sections 13 or 15(d)]